More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML).

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2005-12-5128PMID 16790588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).

  2006cited by this paper
• Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia.

  2006cited by this paper
• Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptake.

  2005cited by this paper
• Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs.

  2005cited by this paper
• AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations.

  2005cited by this paper
• Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.

  2005cited by this paper
• Analysis of the E399D mutation in SLC11A2.

  2005cited by this paper
• Hepcidin in iron overload disorders.

  2005cited by this paper
• Novel FLT3 point mutations within exon  14 found in patients with acute myeloid leukaemia

  2004cited by this paper
• Severe hypochromic microcytic anemia caused by a congenital defect of the iron transport pathway in erythroid cells.

  2004cited by this paper
• FMS-LIKE TYROSINE KINASE (FLT3) GENE ITD MUTATION IN ACUTE MYELOID LEUKEMIA

  2004cited by this paper
• The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

  2002cited by this paper

• Genomic Alterations, Gene Expression Profiles and Functional Enrichment of Normal-Karyotype Acute Myeloid Leukaemia Based on Targeted Next-Generation Sequencing

  2023cites this paper
• 索拉非尼联合维奈克拉、阿扎胞苷方案诱导治疗FLT3-ITD突变阳性急性髓系白血病12例的疗效及安全性分析

  2022cites this paper
• Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis

  2022cites this paper
• Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

  2022cites this paper
• De novo adult acute myeloid leukemia with two new mutations in juxtatransmembrane domain of the FLT3 gene: a case report

  2021cites this paper
• DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia

  2021cites this paper
• Molecular Characterization of Flt3 Mutation in Acute Leukemia

  2021cites this paper
• Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

  2021cites this paper
• DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia

  2021cites this paper
• Prognostic Factors in AML

  2021cites this paper
• FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation

  2021cites this paper
• Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia

  2020cites this paper
• RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML.

  2018cites this paper
• Impact of FLT3-ITD length on prognosis of acute myeloid leukemia

  2018cites this paper
• Clonal heterogeneity of FLT3-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia

  2018cites this paper
• Clinical implications of molecular markers in acute myeloid leukemia

  2018cites this paper
• Pattern and prognostic value of FLT3‐ITD mutations in Chinese de novo adult acute myeloid leukemia

  2018cites this paper
• FLT3–ITD and its current role in acute myeloid leukaemia

  2017cites this paper
• Haematological Malignancies Targeting the FLT 3 Mutation in Acute Myeloid Leukaemia

  2017cites this paper
• FMS-related tyrosine kinase 3 internal tandem duplication (FLT3-ITD): a villain among others

  2017cites this paper
• [The clinical efficacy of the patients of acute myeloid leukemia with FLT3-ITD positive treated with sorafenib in combin ation with CHAG regimen].

  2016cites this paper
• Detection the Frequency and Characteristics of FLT3 Internal Tandem Duplication Mutations by Capillary Electrophoresis Assay and Next-Generation Sequencing in.

  2016cites this paper
• 索拉非尼联合CHAG方案诱导治疗10例FLT3-ITD突变阳性急性髓系白血病患者疗效观察

  2016cites this paper
• Pathology Consultation on Gene Mutations in Acute Myeloid Leukemia.

  2015cites this paper
• FLT3-ITD突变数量、长度及水平对急性髓系白血病患者预后的影响

  2015cites this paper
• DNA damage response and anti-apoptotic proteins expression in NPMc+ mutated cells in acute myeloid leukaemia

  2014cites this paper
• The Biology and Targeting of FLT3 in Pediatric Leukemia

  2014cites this paper
• Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic

  2014cites this paper
• Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort

  2014cites this paper
• Sorafenib as monotherapy or in association with cytarabine and clofarabine for the treatment of relapsed/refractory FLT3 ITD-positive advanced acute myeloid leukemia.

  2014cites this paper
• Genetic prognostic factors in acute myeloid leukemia

  2014cites this paper
• FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations

  2014cites this paper
• Prognostic factors for acute myeloid leukaemia in adults – biological significance and clinical use

  2014cites this paper
• Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.

  2014cites this paper
• The FLT3 Tyrosine Kinase in Leukemia : Deciphering the Downstream Signaling Events and Drug-Escape Mechanisms

  2013cites this paper
• patients with acute myeloid leukemia and interaction with NPM1 mutations in a large cohort of young adult The impact of FLT3 internal tandem duplication mutant level, number, size

  2013cites this paper
• Refining the prognostic importance of the diversity of FLT3 internal tandem duplications

  2013cites this paper
• 뀀Ƞ THE FLT3 TYROSINE KINASE IN LEUKEMIA

  2013cites this paper
• Molecular analysis of different FLT3-ITD mutations in acute myeloid leukemia

  2013cites this paper
• Detection of Minor Clones With Internal Tandem Duplication Mutations of FLT3 Gene in Acute Myeloid Leukemia Using Delta-PCR

  2013cites this paper
• Quantitative Mutationsanalyse des FLT3-Gens bei der akuten myeloischen Leukämie mit normalem Karyotyp

  2012cites this paper
• Hematological characteristics and effective screening for compound heterozygosity for Hb constant spring and deletional α+‐thalassemia

  2011cites this paper
• Nilotinib treatment‐associated peripheral artery disease and sudden death: Yet another reason to stick to imatinib as front‐line therapy for chronic myelogenous leukemia

  2011cites this paper
• Nilotinib treatment-associated peripheral artery disease and sudden death : Yet another reason to stick to imatinib as front-line therapy for chronic myelogenous leukemia

  2011cites this paper
• Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN‐AML) and FLT3ITD

  2011cites this paper
• Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia.

  2010cites this paper
• FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657.

  2010cites this paper
• FLT 3 as a therapeutic target in AML : still challenging after all these years

  2010cites this paper
• FLT3 as a therapeutic target in AML: still challenging after all these years.

  2010cites this paper
• Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

  2009cites this paper
• Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome.

  2009cites this paper
• FLT3‐ITD expression levels and their effect on STAT5 in AML with and without NPM mutations

  2009cites this paper
• Thalidomide and lenalidomide: Mechanism-based potential drug combinations

  2008cites this paper
• The Role of Bortezomib in the Treatment of Relapsed and Refractory Multiple Myeloma

  2008cites this paper
• The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

  2008cites this paper
• VTD combination therapy with bortezomib–thalidomide–dexamethasone is highly effective in advanced and refractory multiple myeloma

  2008cites this paper
• An update on drug combinations for treatment of myeloma

  2008cites this paper
• Cooperating gene mutations in acute myeloid leukemia: a review of the literature

  2008cites this paper
• Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential.

  2007cites this paper
• New horizons in the characterization and treatment of acute myeloid leukemia

  2007cites this paper
• Lenalidomide in the treatment of multiple myeloma.

  2007cites this paper
• High HSP70-membrane expression on leukemic cells from patients with acute myeloid leukemia is associated with a worse prognosis

  2006cites this paper
• The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients

  2006cites this paper
• Investigations of FLT3 internal tandem duplications in patients with acute myeloid leukaemia

  2006cites this paper